Role of Corpus Callosum Volumetry in Differentiating the Subtypes of Progressive Supranuclear Palsy and Early Parkinson's Disease

Progressive supranuclear palsy (PSP) is a progressive neurodegenerative disorder. Classic PSP or Richardson‐Steele phenotype (PSP‐RS) and parkinsonian phenotype (PSP‐P) are the common subtypes of PSP. At the early stage, differentiating the subtypes of PSP as well as differentiating PSP from other parkinsonian disorders, especially Parkinson's disease (PD) is challenging. Microstructural abnormalities of corpus callosum (CC) have been reported both in PSP and PD. The objective of this study was to compare the volumes of various segments of CC between patients with PSP‐P, PSP‐RS, and early PD.

[1]  Nikolaus R. McFarland,et al.  Distinct patterns of brain activity in progressive supranuclear palsy and Parkinson's disease , 2015, Movement disorders : official journal of the Movement Disorder Society.

[2]  Jens Frahm,et al.  Topography of the human corpus callosum revisited—Comprehensive fiber tractography using diffusion tensor magnetic resonance imaging , 2006, NeuroImage.

[3]  J. Kaye,et al.  Corpus Callosum in Neurodegenerative Diseases: Findings in Parkinson’s Disease , 2005, Dementia and Geriatric Cognitive Disorders.

[4]  T. Hattori,et al.  Diffusion tensor analysis of corpus callosum in progressive supranuclear palsy , 2008, Neuroradiology.

[5]  C. Derouesné.  [Mini-mental state examination]. , 2001, Revue neurologique.

[6]  P. Mcgeer,et al.  Appearance of paired nucleated, Tau-positive glia in patients with progressive supranuclear palsy brain tissue , 1992, Neuroscience Letters.

[7]  K. Thennarasu,et al.  Subcortical structures in progressive supranuclear palsy: vertex‐based analysis , 2013, European journal of neurology.

[8]  D Perani,et al.  Diffusion tensor imaging and voxel based morphometry study in early progressive supranuclear palsy , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[9]  A. Bizzi,et al.  Diffusion Tensor Imaging Shows Different Topographic Involvement of the Thalamus in Progressive Supranuclear Palsy and Corticobasal Degeneration , 2009, American Journal of Neuroradiology.

[10]  A. Berardelli,et al.  Abnormal cortical synaptic plasticity in primary motor area in progressive supranuclear palsy. , 2012, Cerebral cortex.

[11]  David R Williams,et al.  Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges , 2009, The Lancet Neurology.

[12]  P. R. Hof,et al.  Distribution of cortical neurofibrillary tangles in progressive supranuclear palsy: A quantitative analysis of six cases , 2004, Acta Neuropathologica.

[13]  Michel Goedert,et al.  Tau protein and neurodegeneration. , 2004, Seminars in cell & developmental biology.

[14]  Masanori Kato,et al.  Immunohistochemical investigation of tau-positive structures in the cerebral cortex of patients with progressive supranuclear palsy , 1995, Neuroscience Letters.

[15]  P. Pal,et al.  In vivo evaluation of white matter pathology in patients of progressive supranuclear palsy using TBSS , 2012, Neuroradiology.

[16]  E. Bigio,et al.  Cortical Synapse Loss in Progressive Supranuclear Palsy , 2001, Journal of neuropathology and experimental neurology.

[17]  H. Fukuyama,et al.  Atrophy of the corpus callosum, cognitive impairment, and cortical hypometabolism in progressive supranuclear palsy , 1997, Annals of neurology.

[18]  A. Albanese,et al.  White Matter Involvement in Idiopathic Parkinson Disease: A Diffusion Tensor Imaging Study , 2009, American Journal of Neuroradiology.

[19]  L. Golbe,et al.  A clinical rating scale for progressive supranuclear palsy. , 2007, Brain : a journal of neurology.

[20]  David N. Kennedy,et al.  Human cerebral cortex: A system for the integration of volume- and surface-based representations , 2006, NeuroImage.

[21]  A. Lees,et al.  Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism. , 2005, Brain : a journal of neurology.

[22]  G. Hynd,et al.  The Role of the Corpus Callosum in Interhemispheric Transfer of Information: Excitation or Inhibition? , 2005, Neuropsychology Review.

[23]  M. Hallett,et al.  Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) , 1996, Neurology.

[24]  J. Olszewski,et al.  SUPRANUCLEAR OPHTHALMOPLEGIA, PSEUDOBULBAR PALSY, NUCHAL DYSTONIA AND DEMENTIA. A CLINICAL REPORT ON EIGHT CASES OF "HETEROGENOUS SYSTEM DEGENERATION". , 1963, Transactions of the American Neurological Association.

[25]  G. Halliday,et al.  A comparison of degeneration in motor thalamus and cortex between progressive supranuclear palsy and Parkinson's disease. , 2005, Brain : a journal of neurology.

[26]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[27]  C. Pozzilli,et al.  No Differences in Corpus Callosum Size by Sex and Aging , 1994, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[28]  Gareth J. Barker,et al.  Diffusion Tensor Imaging of Parkinson’s Disease, Multiple System Atrophy and Progressive Supranuclear Palsy: A Tract-Based Spatial Statistics Study , 2014, PloS one.

[29]  E. Mooshagian,et al.  Anatomy of the Corpus Callosum Reveals Its Function , 2008, The Journal of Neuroscience.

[30]  Anders M. Dale,et al.  An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest , 2006, NeuroImage.

[31]  Peng Yu,et al.  Altered white matter microstructure in the corpus callosum in Huntington's disease: Implications for cortical “disconnection” , 2010, NeuroImage.

[32]  A. Lees,et al.  Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome. , 2007, Brain : a journal of neurology.